Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse.

Raza SM, Habib A, Wang WL, Gildey PW, Conley AP, Nader ME, Hanna EY, Su SY, DeMonte F.

Neurosurgery. 2019 Sep 12. pii: nyz360. doi: 10.1093/neuros/nyz360. [Epub ahead of print]

PMID:
31515560
2.

Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.

Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, Ferrarotto R, Glisson B, Kupferman ME, Roberts DB, Su SY, Raza SM, DeMonte F, Hanna EY.

J Clin Oncol. 2019 Feb 20;37(6):504-512. doi: 10.1200/JCO.18.00353. Epub 2019 Jan 7.

3.

Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity.

Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY.

Head Neck. 2018 Dec;40(12):2596-2605. doi: 10.1002/hed.25335. Epub 2018 Nov 17.

PMID:
30447126
4.

Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension.

Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM.

J Neurosurg. 2018 Jul 1:1-8. doi: 10.3171/2018.3.JNS172722. [Epub ahead of print]

PMID:
30074455
5.

Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.

Freeman JL, Kaufmann AB, Everson RG, DeMonte F, Raza SM.

Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):27-36. doi: 10.1093/ons/opy073.

PMID:
29912434
6.

Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors.

Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F.

J Neurosurg. 2018 Apr 27;130(3):812-821. doi: 10.3171/2017.11.JNS172084.

PMID:
29701557
7.

A gene expression signature predicts recurrence-free survival in meningioma.

Olar A, Goodman LD, Wani KM, Boehling NS, Sharma DS, Mody RR, Gumin J, Claus EB, Lang FF, Cloughesy TF, Lai A, Aldape KD, DeMonte F, Sulman EP.

Oncotarget. 2018 Feb 15;9(22):16087-16098. doi: 10.18632/oncotarget.24498. eCollection 2018 Mar 23.

8.

Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.

Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY.

Ann Surg Oncol. 2018 Jun;25(6):1723-1729. doi: 10.1245/s10434-018-6465-y. Epub 2018 Apr 6.

PMID:
29626308
9.

Developmental Considerations in Pediatric Skull Base Surgery.

LoPresti MA, Sellin JN, DeMonte F.

J Neurol Surg B Skull Base. 2018 Feb;79(1):3-12. doi: 10.1055/s-0037-1617449. Epub 2018 Jan 5. Review.

10.

Intracranial dural, calvarial, and skull base metastases.

Harrison RA, Nam JY, Weathers SP, DeMonte F.

Handb Clin Neurol. 2018;149:205-225. doi: 10.1016/B978-0-12-811161-1.00014-1. Review.

PMID:
29307354
11.

Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma).

Mehta GU, Hanna EY, DeMonte F, Raza SM.

Acta Neurochir (Wien). 2018 Feb;160(2):361-366. doi: 10.1007/s00701-017-3437-0. Epub 2017 Dec 26.

PMID:
29277853
12.

Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma.

Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM.

Acta Neurochir (Wien). 2018 Apr;160(4):731-740. doi: 10.1007/s00701-017-3409-4. Epub 2017 Dec 21.

PMID:
29270681
13.

Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.

Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY.

Laryngoscope. 2018 Jun;128(6):1274-1280. doi: 10.1002/lary.26908. Epub 2017 Dec 11.

PMID:
29226334
14.

Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma.

Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY.

J Neurol Surg B Skull Base. 2017 Dec;78(6):512-518. doi: 10.1055/s-0037-1604350. Epub 2017 Jul 31.

15.

Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.

Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY.

Cancer. 2018 Feb 1;124(3):514-520. doi: 10.1002/cncr.31083. Epub 2017 Oct 17.

16.

Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival.

Raza SM, Bell D, Freeman JL, Grosshans DR, Fuller GN, DeMonte F.

Oper Neurosurg (Hagerstown). 2018 Aug 1;15(2):131-143. doi: 10.1093/ons/opx201.

PMID:
29040778
17.

Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas.

Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte F.

Oper Neurosurg (Hagerstown). 2018 Jun 1;14(6):611-619. doi: 10.1093/ons/opx171.

PMID:
28962038
18.

Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.

Bell AH, DeMonte F, Raza SM, Rhines LD, Tatsui CE, Prieto VG, Fuller GN, Bell D.

Virchows Arch. 2018 Mar;472(3):489-497. doi: 10.1007/s00428-017-2224-x. Epub 2017 Aug 27.

PMID:
28844110
19.

The First Reported Case of Primary Intestinal-type Adenocarcinoma of the Middle Ear and Review of the Literature.

Nader ME, Bell D, Ginsberg L, DeMonte F, Gunn GB, Gidley PW.

Otol Neurotol. 2017 Oct;38(9):e364-e368. doi: 10.1097/MAO.0000000000001541. Review.

PMID:
28796082
20.

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G.

Lancet Oncol. 2017 Aug;18(8):1040-1048. doi: 10.1016/S1470-2045(17)30414-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433. Lancet Oncol. 2017 Sep;18(9):e510.

21.

Mutation status among patients with sinonasal mucosal melanoma and its impact on survival.

Amit M, Tam S, Abdelmeguid AS, Roberts DB, Takahashi Y, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY.

Br J Cancer. 2017 Jun 6;116(12):1564-1571. doi: 10.1038/bjc.2017.125. Epub 2017 May 11.

22.

Surgical Resection of an Optic Nerve Sheath Meningioma: Relevance of Endoscopic Endonasal Approaches to the Optic Canal.

Hunt PJ, DeMonte F, Tang RA, Su SY, Raza SM.

J Neurol Surg Rep. 2017 Apr;78(2):e81-e85. doi: 10.1055/s-0037-1600897.

23.

Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols.

Raza SM, Gidley PW, Meis JM, Grosshans DR, Bell D, DeMonte F.

Neurosurgery. 2017 Sep 1;81(3):520-530. doi: 10.1093/neuros/nyx042. Erratum in: Neurosurgery. 2017 Dec 1;81(6):1047.

PMID:
28368506
24.

Overt and Subclinical Baroreflex Dysfunction After Bilateral Carotid Body Tumor Resection: Pathophysiology, Diagnosis, and Implications for Management.

Ghali MGZ, Srinivasan VM, Hanna E, DeMonte F.

World Neurosurg. 2017 May;101:559-567. doi: 10.1016/j.wneu.2017.02.073. Epub 2017 Feb 27. Review.

PMID:
28245992
25.

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.

Olar A, Wani KM, Wilson CD, Zadeh G, DeMonte F, Jones DT, Pfister SM, Sulman EP, Aldape KD.

Acta Neuropathol. 2017 Mar;133(3):431-444. doi: 10.1007/s00401-017-1678-x. Epub 2017 Jan 27.

26.

Whole-transcriptome analysis of chordoma of the skull base.

Bell D, Raza SM, Bell AH, Fuller GN, DeMonte F.

Virchows Arch. 2016 Oct;469(4):439-49. doi: 10.1007/s00428-016-1985-y. Epub 2016 Jul 11.

PMID:
27401718
27.

Management of Skull Base Tumor-Associated Facial Pain.

Reddy GD, Wagner K, Phan J, DeMonte F, Raza SM.

Neurosurg Clin N Am. 2016 Jul;27(3):337-44. doi: 10.1016/j.nec.2016.02.009. Review.

PMID:
27325000
28.

Petroclival Chondrosarcoma: A Multicenter Review of 55 Cases and New Staging System.

Carlson ML, O'Connell BP, Breen JT, Wick CC, Driscoll CL, Haynes DS, Thompson RC, Isaacson B, Gidley PW, Kutz JW Jr, Van Gompel JJ, Wanna GB, Raza SM, DeMonte F, Barnett SL, Link MJ.

Otol Neurotol. 2016 Aug;37(7):940-50. doi: 10.1097/MAO.0000000000001037.

PMID:
27273403
29.

The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):241-7. doi: 10.1016/j.prro.2015.10.023. Epub 2015 Nov 10.

30.

Chondromyxoid Fibroma of the Skull Base and Calvarium: Surgical Management and Literature Review.

Yaghi NK, DeMonte F.

J Neurol Surg Rep. 2016 Mar;77(1):e023-34. doi: 10.1055/s-0035-1570033. Epub 2016 Jan 4.

31.

Contrast-enhanced Reformatted MR Images for Preoperative Assessment of the Bridging Veins of the Skull Base.

Wangaryattawanich P, Chavali LS, Shah KB, Gogia B, Valenzuela RF, DeMonte F, Kumar AJ, Hayman LA.

Radiographics. 2016 Jan-Feb;36(1):244-57. doi: 10.1148/rg.2016150084. Review.

PMID:
26761539
32.

Non-contiguous meningeal metastases of olfactory neuroblastoma.

Jiang W, Liu J, Gullane PJ, Gentili F, Wharen RE, Kim BYS, DeMonte F.

J Neurooncol. 2016 Jan;126(1):201-203. doi: 10.1007/s11060-015-1935-6. Epub 2015 Sep 16.

PMID:
26376653
33.

Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach.

Ramakrishna R, Raza SM, Kupferman M, Hanna E, DeMonte F.

J Neurosurg. 2016 Jan;124(1):115-21. doi: 10.3171/2015.1.JNS142462. Epub 2015 Aug 7.

PMID:
26252456
34.

Neuroendocrine neoplasms of the sinonasal region.

Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-OrdoƱez B, Williams MD, Takes RP, Ferlito A.

Head Neck. 2016 Apr;38 Suppl 1:E2259-66. doi: 10.1002/hed.24152. Epub 2015 Jul 18. Review.

PMID:
26041714
35.

Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.

Raza SM, Ramakrishna R, Weber RS, Kupferman ME, Gidley PW, Hanna EY, DeMonte F.

J Neurosurg. 2015 Sep;123(3):781-8. doi: 10.3171/2014.10.JNS141037. Epub 2015 Apr 24.

PMID:
25909577
36.

Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region.

Edson MA, Fuller GN, Allen PK, Levine NB, Ghia AJ, Mahajan A, Brown PD, DeMonte F, Li J.

World Neurosurg. 2015 Jul;84(1):76-81. doi: 10.1016/j.wneu.2015.02.031. Epub 2015 Mar 5.

PMID:
25749579
37.

Radiation-associated malignancies of the ear canal and temporal bone.

Lambert EM, Garden AS, DeMonte F, Roberts DB, Gidley PW.

Laryngoscope. 2015 May;125(5):1198-204. doi: 10.1002/lary.25071. Epub 2014 Dec 4.

PMID:
25476255
38.

Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.

Grosshans DR, Zhu XR, Melancon A, Allen PK, Poenisch F, Palmer M, McAleer MF, McGovern SL, Gillin M, DeMonte F, Chang EL, Brown PD, Mahajan A.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):540-6. doi: 10.1016/j.ijrobp.2014.07.005. Epub 2014 Sep 26.

PMID:
25304948
39.

Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery.

Alves MV, Roberts D, Levine NB, DeMonte F, Hanna EY, Kupferman ME.

J Neurol Surg B Skull Base. 2014 Oct;75(5):354-7. doi: 10.1055/s-0034-1373659. Epub 2014 Jun 4.

40.

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD.

Brain Pathol. 2015 May;25(3):266-75. doi: 10.1111/bpa.12174. Epub 2014 Oct 29.

41.

Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.

Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, Hanna EY.

Head Neck Pathol. 2015 Mar;9(1):51-9. doi: 10.1007/s12105-014-0547-3. Epub 2014 May 8.

42.

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Kim BYS, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE.

J Neurooncol. 2014 Jun;118(2):405-412. doi: 10.1007/s11060-014-1451-0. Epub 2014 Apr 29.

43.

Endoscopic resection of sinonasal cancers.

Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY.

Curr Oncol Rep. 2014 Feb;16(2):369. doi: 10.1007/s11912-013-0369-6. Review.

PMID:
24445501
44.

Retrosigmoid craniotomy for cerebellopontine angle/petroclival epidermoid cyst.

Raza SM, DeMonte F.

Neurosurg Focus. 2014 Jan;36(1 Suppl):1. doi: 10.3171/2014.V1.FOCUS13436.

PMID:
24380519
45.

Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors.

Debnam JM, Mayer RR, Esmaeli B, Weinberg JS, Demonte F, Guha-Thakurta N.

J Ophthalmol. 2013;2013:674230. doi: 10.1155/2013/674230. Epub 2013 Oct 31.

46.

Outcomes of calvarial reconstruction in cancer patients.

Lee EI, Chao AH, Skoracki RJ, Yu P, DeMonte F, Hanasono MM.

Plast Reconstr Surg. 2014 Mar;133(3):675-82. doi: 10.1097/01.prs.0000438061.46290.33.

PMID:
24263391
47.

Sinonasal adenocarcinoma: a 16-year experience at a single institution.

Bhayani MK, Yilmaz T, Sweeney A, Calzada G, Roberts DB, Levine NB, DeMonte F, Hanna EY, Kupferman ME.

Head Neck. 2014 Oct;36(10):1490-6. doi: 10.1002/hed.23485. Epub 2014 Jan 29.

PMID:
23996784
48.

Optimization of long-term outcomes for patients with esthesioneuroblastoma.

Ow TJ, Hanna EY, Roberts DB, Levine NB, El-Naggar AK, Rosenthal DI, DeMonte F, Kupferman ME.

Head Neck. 2014 Apr;36(4):524-30. doi: 10.1002/hed.23327. Epub 2013 Jun 18.

PMID:
23780581
49.

Malignant tumors of the skull base. Preface.

Bloch O, Demonte F.

Neurosurg Clin N Am. 2013 Jan;24(1):xi-xii. doi: 10.1016/j.nec.2012.08.012. Epub 2012 Sep 23. No abstract available.

PMID:
23174364
50.

Temporal bone malignancies.

Gidley PW, DeMonte F.

Neurosurg Clin N Am. 2013 Jan;24(1):97-110. doi: 10.1016/j.nec.2012.08.009. Review.

PMID:
23174361

Supplemental Content

Loading ...
Support Center